ER Proteins Effect on Class I MHC Assembly
ER 蛋白对 I 类 MHC 组装的影响
基本信息
- 批准号:7922974
- 负责人:
- 金额:$ 8.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-15 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAffinityAntigen PresentationAreaArthritisAutoimmune DiseasesAutoimmunityBindingBiochemicalBiochemistryCell physiologyCell surfaceCellsClinical Cancer CenterCollaborationsComplexCytolysisCytotoxic T-LymphocytesDevelopmentDiabetes MellitusDiseaseERp57Endoplasmic ReticulumFundingGoalsGraft RejectionGrantHeadImmune responseImmunologistImmunotherapeutic agentIn VitroInfectionInfectious AgentInstitutesLigandsMajor Histocompatibility ComplexMalignant - descriptorMalignant NeoplasmsMass Spectrum AnalysisMolecularNatural Killer CellsNebraskaNeoplasm TransplantationPeptidesPlayPrincipal InvestigatorProteinsRecruitment ActivityRegulationResearchResearch InstituteRoleScientistSiteSpeedSurfaceSystemT-LymphocyteTechnical ExpertiseTechnologyTherapeuticThymus GlandUniversitiesVirginiaVirusantigenic peptide transporterauthoritycalreticulincytotoxicdefined contributionexpectationimprovedin vivoinnovationmutantpathogenpeptide Iprogramsprotein complexresponsetapasintherapy developmenttransplantation medicinetumorvaccine development
项目摘要
DESCRIPTION (provided by applicant): MHC presentation of peptide has broad importance, as shown by the range of disease conditions influenced by MHC molecules, e.g. infections, tumors, transplantation rejection, and autoimmunity. Cell surface major histocompatibility complex (MHC) class I molecules present tumor- or pathogen-specific peptides to T cells, which respond by lysing malignant or infected cells. Self-MHC class I/peptide complexes are required for the primary selection of the host's repertoire of cytolytic T lymphocytes. In addition, the number of surface MHC class I molecules on target cells influences their recognition by natural killer cells. For all these reasons, cell surface expression of peptide-bearing MHC class I molecules is of immunological importance. Before egress to the cell surface, MHC class I molecules receive peptides within a complex of proteins in the endoplasmic reticulum. In the peptide-loading complex, the protein calreticulin binds to the MHC class I heavy chain, and its presence in the complex is up-regulated by tapasin. Tapasin binds to the MHC class I heavy chain, recruits ERp57 and the transporter associated with antigen processing (TAP), and stabilizes TAP. Although tapasin serves as a critical factor in the control of MHC class I surface expression and peptide presentation, the mechanisms whereby it regulates MHC class I assembly are poorly understood.
A more complete understanding of the importance of MHC class I peptide-loading complex interactions involving tapasin would contribute to the creation of strategies to influence peptide presentation for many therapeutic purposes. The objective of this project is to define the mechanisms by which antigen presentation by MHC class I molecules is regulated. Our central hypothesis is that specific interactions of tapasin with other assembly complex proteins regulate the sequence and affinity of MHC class I-binding peptides, the stability of MHC class I/p2m heterodimers prior to final peptide binding, and ultimately cytotoxic T lymphocyte selection and response. We propose these Aims: 1) to determine the role of peptide-loading complex interactions in the stabilization of complete MHC molecules and in the regulation of the MHC class I peptide repertoire, 2) to define the effect of assembly complex interactions on the stability of open MHC class I/p2m heterodimers, and 3) to characterize the impact of peptide-loading complex interactions on T cell recognition, response, and development, using in vitro and in vivo systems. At the completion of this project, it is our expectation that we will have defined contributions of the peptide-loading complex involving tapasin to the regulation of the MHC class I-binding peptide repertoire, MHC class I stabilization, and T cell function.
描述(由申请人提供):MHC的肽表现具有广泛的重要性,如受MHC分子影响的疾病范围所示,例如感染,肿瘤,移植排斥和自身免疫性。细胞表面主要的组织相容性复合物(MHC)I类分子向T细胞呈现肿瘤或病原体特异性肽,这些肽是通过裂解恶性或感染细胞反应的。自我MHC I/肽复合物是宿主胞质T淋巴细胞曲目的主要选择所必需的。另外,靶细胞上的表面MHC I类分子的数量会影响自然杀伤细胞的识别。由于所有这些原因,含有肽的MHC I类分子的细胞表面表达具有免疫学重要性。在出口到细胞表面之前,MHC I类分子在内质网中的蛋白质复合物中接受肽。在肽加载络合物中,蛋白钙网蛋白与MHC I类重链结合,其在复合物中的存在被木薯素上调。小吃结合了MHC I类重链,招募ERP57和与抗原加工(TAP)相关的转运蛋白,并稳定TAP。尽管小吃是控制MHC I类表面表达和肽表现的关键因素,但调节MHC I类组装的机制知之甚少。
对MHC I类肽的重要性的重要性更完整地理解涉及木薯素的复杂相互作用将有助于创建影响许多治疗目的的肽表现的策略。该项目的目的是定义MHC I类分子的抗原表现的机制。我们的中心假设是,木薯素与其他组装复合蛋白的特定相互作用调节MHC I类结合肽的序列和亲和力,MHC类I/P2M类异二聚体在最终肽结合之前的稳定性,以及最终最终导致细胞毒性T淋巴细胞的选择和反应。 We propose these Aims: 1) to determine the role of peptide-loading complex interactions in the stabilization of complete MHC molecules and in the regulation of the MHC class I peptide repertoire, 2) to define the effect of assembly complex interactions on the stability of open MHC class I/p2m heterodimers, and 3) to characterize the impact of peptide-loading complex interactions on T cell recognition, response, and开发,使用体外和体内系统。该项目完成后,我们期望我们将定义涉及木薯素对MHC I类结合肽库,MHC I类稳定和T细胞功能调节的肽加载络合物的贡献。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Analysis of major histocompatibility complex class I interactions with endoplasmic reticulum proteins.
- DOI:10.1385/1-59259-062-4:165
- 发表时间:2001
- 期刊:
- 影响因子:0
- 作者:H. Turnquist;J. Solheim
- 通讯作者:H. Turnquist;J. Solheim
Effect of linkage of transduction domain sequences to a lymphoma idiotype DNA vaccine on vaccine effectiveness.
转导结构域序列与淋巴瘤独特型 DNA 疫苗的连接对疫苗有效性的影响。
- DOI:10.1089/hyb.2006.25.306
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Ashour,Abdel-Kader;Petersen,JasonL;McIlhaney,MaryM;Vose,JulieM;Solheim,JoyceC
- 通讯作者:Solheim,JoyceC
Specificity of amyloid precursor-like protein 2 interactions with MHC class I molecules.
淀粉样前体样蛋白 2 与 MHC I 类分子相互作用的特异性。
- DOI:10.1007/s00251-008-0296-0
- 发表时间:2008
- 期刊:
- 影响因子:3.2
- 作者:Tuli,Amit;Sharma,Mahak;Naslavsky,Naava;Caplan,Steve;Solheim,JoyceC
- 通讯作者:Solheim,JoyceC
An extensive region of an MHC class I alpha 2 domain loop influences interaction with the assembly complex.
MHC I 类 α2 结构域环的广泛区域影响与组装复合物的相互作用。
- DOI:
- 发表时间:1999
- 期刊:
- 影响因子:0
- 作者:Yu,YY;Turnquist,HR;Myers,NB;Balendiran,GK;Hansen,TH;Solheim,JC
- 通讯作者:Solheim,JC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joyce C Solheim其他文献
Joyce C Solheim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joyce C Solheim', 18)}}的其他基金
Ewing's Sarcoma Resistance to Immunity and Radiation
尤文氏肉瘤对免疫和辐射的抵抗力
- 批准号:
8502033 - 财政年份:2013
- 资助金额:
$ 8.96万 - 项目类别:
Ewing's Sarcoma Resistance to Immunity and Radiation
尤文氏肉瘤对免疫和辐射的抵抗力
- 批准号:
8620629 - 财政年份:2013
- 资助金额:
$ 8.96万 - 项目类别:
Effect of Beta-secretase Inhibitors on Pancreatic Cancer Cells
β-分泌酶抑制剂对胰腺癌细胞的作用
- 批准号:
8508899 - 财政年份:2012
- 资助金额:
$ 8.96万 - 项目类别:
Effect of Beta-secretase Inhibitors on Pancreatic Cancer Cells
β-分泌酶抑制剂对胰腺癌细胞的作用
- 批准号:
8358516 - 财政年份:2012
- 资助金额:
$ 8.96万 - 项目类别:
PROJECT 4:MECHANISMS FACILITATING GROWTH & METASTASIS OF PANCREATIC CANCER
项目 4:促进增长的机制
- 批准号:
8360444 - 财政年份:2011
- 资助金额:
$ 8.96万 - 项目类别:
ER PROTEINS EFFECT ON CLASS I MHC ASSEMBLY
ER 蛋白对 I 类 MHC 组装的影响
- 批准号:
6386870 - 财政年份:1998
- 资助金额:
$ 8.96万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
- 批准号:
10724882 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
Fibroblasts in the establishment of the liver pre-metastatic niche
成纤维细胞在肝脏转移前生态位的建立中
- 批准号:
10742193 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
Characterizing molecular phenotypes of pancreatic islet reactive B cells in T1D through single cell sequencing
通过单细胞测序表征 T1D 中胰岛反应性 B 细胞的分子表型
- 批准号:
10600510 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别: